Evelo Biosciences Analyst Ratings
Morgan Stanley Adjusts Evelo Biosciences' Price Target to $10 From $2, Keeps Equalweight Rating
Morgan Stanley Maintains Equal-Weight on Evelo Biosciences, Raises Price Target to $10
Evelo Biosciences Analyst Ratings
Evelo Biosciences (EVLO) Gets a Hold From Morgan Stanley
Analysts Offer Insights on Healthcare Companies: Star Equity Holdings (STRR), Evelo Biosciences (EVLO) and 4D Molecular Therapeutics (FDMT)
Evelo Biosciences Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: BioMarin Pharmaceutical (BMRN), DarioHealth (DRIO) and Evelo Biosciences (EVLO)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Align Tech (ALGN), Boston Scientific (BSX) and Evelo Biosciences (EVLO)
Evelo Biosciences Analyst Ratings
Chardan Downgrades Evelo Biosciences to Neutral From Buy, Cuts Price Target to $2.50 From $5